Email Facebook Twitter

RNS EXCLUSIVE: Cabot praise 3D seismic mapping after successful winter programme

Astrazeneca Share News (AZN)

Stock Market news at - RSS News Feeds

Share News for Astrazeneca (AZN)

Share Price: 4,788.00Bid: 4,790.50Ask: 4,791.50Change: 0.00 (0.00%)No Movement on Astrazeneca
Spread: 1.00Spread as %: 0.02%Open: 4,803.50High: 4,820.50Low: 4,756.00Yesterday’s Close: 4,788.00

FOCUS-GlaxoSmithKline prescribes commercial reboot for pharma division

* GSK reallocating budget to key new drugs, top 10 markets* Pharma head says commercial revamp matches R&D changes* Cancer a big pipeline focus, promi
[21 Mar '18 07:00]

BUZZ-AstraZeneca: Jefferies upgrades

** AstraZeneca among top pct gainers on FTSE 100 index** Jefferies raises recommendation to "Buy" from "Hold"; says AstraZeneca "is at a turning point
[19 Mar '18 08:17]

AstraZeneca sees pivotal lung cancer trial results later in 2018

LONDON, March 12 (Reuters) - AstraZeneca now expects a key lung cancer study of two immunotherapy drugs to produce overall survival results in the sec
[12 Mar '18 07:36]

UPDATE 1-Merck, Eisai sign deal to further develop, sell Eisai cancer drug

(Adds company comment, deal details, background)By Bill BerkrotMarch 7 (Reuters) - Merck & Co Inc and Japan's Eisai Co Ltd on Wednesday announced a po
[7 Mar '18 23:11]

CORRECTED-UPDATE 3-Eisai clinches Merck deal to develop and sell cancer drug, shares soar

(In March 8 story in 7th paragraph corrects to show Merck will pay, not receive, R&D reimbursement)* Deal could be worth up to $5.76 billion to Eisai*
[7 Mar '18 23:11]

Merck, Eisai sign deal to further develop, sell Eisai cancer drug

March 7 (Reuters) - Merck & Co and Japan's Eisai Co Ltd on Wednesday announced a potential multibillion-dollar collaboration to develop and sell Eisai
[7 Mar '18 22:16]

Novo Nordisk gets nod from U.S. drug purchaser for new diabetes hope

By Jacob Gronholt-PedersenCOPENHAGEN, Feb 21 (Reuters) - Insulin maker Novo Nordisk said its Ozempic diabetes drug had been included on a list of medi
[21 Feb '18 16:52]

LIVE MARKETS-Closing snapshot: a lacklustre start to the week

* European shares end lower * Wall St closed for holiday * Reckitt leads fallers as update disappoints Feb 19 (Reuters) - Welcome to the
[19 Feb '18 16:53]

Share Price, Share Chat, Stock Market news at
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at

Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.